This browser does not support the video element.

Sep. 10, 2020

AstraZeneca says it should know by end of year if its vaccine will protect from COVID-19

AstraZeneca's chief executive Pascal Soriot said late-stage trials were suspended after a study subject fell ill in Britain. The person was reportedly suffering from neurological symptoms.